日韩精品久久一区二区三区_亚洲色图p_亚洲综合在线最大成人_国产中出在线观看_日韩免费_亚洲综合在线一区

Global EditionASIA 中文雙語Fran?ais
World
Home / World / Americas

Brazil begins COVID inoculations of two vaccines including China's CoronaVac

By SERGIO HELD in Cajica, Colombia | chinadaily.com.cn | Updated: 2021-01-19 16:48
Share
Share - WeChat
Nurse Monica Calazans, 54, receives a dose of the Sinovac's coronavirus disease (COVID-19) vaccine from nurse Jessica Pires de Camargo, 30, after Brazil health regulator Anvisa approved its emergency use at Hospital das Clinicas in Sao Paulo, Brazil, Jan 17, 2021. [Photo/Agencies]

Brazilian nurse Monica Calazans has become Brazil's first person to receive China-related vaccine. Now in her 50s, she got the jab on Jan 17 despite a series of underlying conditions, including diabetes, hypertension and obesity.

The COVID-19 vaccine CoronaVac, developed by China's Sinovac Biotech, won emergency approval on Jan 17 from regulators in Brazil as the country geared up for a mass immunization program amid a second wave of the pandemic.

Anvisa, Brazil's regulatory agency, also cleared Covishield developed by Astrazeneca plc and the University of Oxford, for emergency use, paving way for start of the national inoculation campaign.

"Today is a historical day for Brazilian science. Anvisa has just approved by majority the emergency use of the Butantan vaccine. Science victory. Victory of life. Victory of Brazil," said Sao Paulo Governor Joao Doria after learning of Anvisa's decision.

"Altogether, 4,636,936 doses of the Butantan vaccine are being sent to the Ministry of Health for distribution to the Federal District and other states," he said.

By 8 pm local time on Jan 17, about 100 healthcare workers in Sao Paulo had received the Chinese vaccine, according to Doria.

The Butantan Institute, a Sao Paulo state government entity that enjoys the distinction of being the largest flu vaccine manufacturer in the Southern Hemisphere, will manufacture and distribute CoronaVac.

"Chinese science has shown it has leverage to create a different global political economy of vaccines. Due to western polarization of the pandemic, everybody now pays attention to the fact that the vaccine is Chinese," said Andre Lobato, a China researcher at the Center for International Relations in Fiocruz, a Rio de Janeiro-based institution that is involved in research and development in biological sciences.

"By themselves, Chinese have identified, isolated, sequenced and began clinical trials," noted Lobato, who is a member of Observa China, a global network of Portuguese speaking professionals with links to China.

CoronaVac underwent phase three trials in Brazil involving 13,000 volunteers that work in health care. Results released in the past week suggest the vaccine is more than 50 percent effective against all severities of COVID-19 and 100 percent effective against more serious cases that would require hospitalization.

"It is an excellent vaccine waiting to be used in a country where, at the moment, around a thousand people die every day," said Dimas Covas, director of the Butantan Institute.

The operation to start distributing the CoronaVac vaccine in Brazil started minutes after Anvisa's approval.

The CoronaVac doses have been available in Brazil since late December.

"Even politicians that antagonize with the socialist model of China are now relying on China biotech to call the shots in their favor," said Lobato from Fiocruz. "This is the case of Brazil."

Brazil has recorded more than 8.5 million infections of COVID-19 and 209,000 deaths, one of the highest tolls in the world.

"The emergency use authorization procedure assesses the suitability of vaccine candidates against Covid-19 for use during the current public health emergency, in order to minimize, as quickly as possible, the impacts of the pandemic," said Anvisa.

The pressure on Brazilian President Jair Bolsonaro to start vaccination as soon as possible was high and the availability of the vaccines made it higher.

"It would have worsened considerably if the population perceived political motivations regarding the approval of immunizers in Brazil," Igor Patrick, director of communications at Observa China, said from Rio de Janeiro.

"Bolsonaro has been feeling the effect of this pressure, since his rejection rates reached new records last week and the press has been publicizing the beginning of vaccination in several countries," Patrick said.

Covishield vaccine of AstraZeneca-Oxford University will be manufactured by Fiocruz, using active pharmaceutical ingredients made in China.

"Fiocruz, with the support of the Ministry of Health, has been in permanent contact with AstraZeneca for the release and export of the active pharmaceutical ingredients from China, which has specific protocols for exporting the cargo, and awaits more precise information to confirm the arrival date of the first inputs needed for vaccine production in Brazil," Fiocruz said in a press statement.

The writer is a freelance journalist for China Daily.

Most Viewed in 24 Hours
Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
主站蜘蛛池模板: 国产伦精品一区二区三区高清 | 欧美激情刺激爽免费视频观看 | 精品中文字幕一区 | 国产一区二区三区在线视频 | 中文线码中文高清播放中 | 成人一级大片 | 一级黄色大片 | 久草香蕉 | 日韩一区不卡 | 亚洲视频免费在线观看 | 日本免费视频在线观看 | 亚洲一区二区三区在线免费观看 | 国产精品99久久久久久www | 九九av | 亚洲国产精品久久网午夜 | 青青免费视频精品一区二区 | 日本国产最新一区二区三区 | 色视频免费版高清在线观看 | 国产69久久久欧美黑人A片 | 精品一区中文字幕 | 精品欧美乱码久久久久久 | 日韩a| 视频一区二区三区四区五区 | 国产视频第一页 | 欧美久 | 日韩欧美视频一区二区三区 | 999国产视频 | 成人午夜亚洲影视在线观看 | 国产一区av在线 | 一级看片| 成人全黄三级视频在线观看 | www.夜夜骑.com | 日本翁熄系列乱在线视频 | 美女福利视频国产免费观看 | 亚州va| 欧美18videos性处按摩 | 国产日韩欧美在线 | 午夜精品久久久久久91 | 国产深夜福利视频在线 | 精品久久久久久亚洲综合网 | 性xxxx视频播放免费 |